Targeted delivery of mycobacterial antigens to human dendritic cells via siglec-7 induces robust T cell activation

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1560-1566

  Kawasaki, Norihito ^a,d   Rillahan, Cory D ^a,e   Cheng, Tan Yun ^b   Van Rhijn, Ildiko ^b,c   Macauley, Matthew S ^a   Moody, D Branch ^b   Paulson, James C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

^d INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1B ANTIGEN; CD1C ANTIGEN; EARLY ENDOSOME ANTIGEN 1; GAMMA INTERFERON; GLUCOSE 6 MONOMYCOLATE; GLYCOLIPID; LIPOSOME; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MYCOBACTERIUM ANTIGEN; NANOPARTICLE; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 7; T6 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LIGAND BINDING; LYSOSOME; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION;

ANTIBODIES; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD1; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL LINE; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; GLYCOLIPIDS; HUMANS; INTERFERON-GAMMA; LECTINS; LIPOSOMES; LYMPHOCYTE ACTIVATION; LYSOSOMES; MYCOBACTERIUM; NANOPARTICLES; T-LYMPHOCYTES; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84905983114     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303278     Document Type: Article

References (41)

1. De Libero, G., and L. Mori. 2010. How the immune system detects lipid antigens. Prog. Lipid Res. 49: 120-127.
2. Kasmar, A., I. Van Rhijn, and D. B. Moody. 2009. The evolved functions of CD1 during infection. Curr. Opin. Immunol. 21: 397-403.
3. Brigl, M., and M. B. Brenner. 2004. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
4. Kasmar, A. G., I. Van Rhijn, T. Y. Cheng, M. Turner, C. Seshadri, A. Schiefner, R. C. Kalathur, J. W. Annand, A. De Jong, J. Shires, et al. 2011. CD1b tetramers bind ab T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J. Exp. Med. 208: 1741-1747.
5. Montamat-Sicotte, D. J., K. A. Millington, C. R. Willcox, S. Hingley-Wilson, S. Hackforth, J. Innes, O. M. Kon, D. A. Lammas, D. E. Minnikin, G. S. Besra, et al. 2011. A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J. Clin. Invest. 121: 2493-2503.
6. Layre, E., A. Collmann, M. Bastian, S. Mariotti, J. Czaplicki, J. Prandi, L. Mori, S. Stenger, G. De Libero, G. Puzo, and M. Gilleron. 2009. Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem. Biol. 16: 82-92.
7. Van Rhijn, I., A. Kasmar, A. De Jong, S. Gras, M. Bhati, M. E. Doorenspleet, N. De Vries, D. I. Godfrey, J. D. Altman, W. De Jager, et al. 2013. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat. Immunol. 14: 706-713.
8. Gilleron, M., S. Stenger, Z. Mazorra, F. Wittke, S. Mariotti, G. Böhmer, J. Prandi, L. Mori, G. Puzo, and G. De Libero. 2004. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 199: 649-659.
9. Moody, D. B., B. B. Reinhold, M. R. Guy, E. M. Beckman, D. E. Frederique, S. T. Furlong, S. Ye, V. N. Reinhold, P. A. Sieling, R. L. Modlin, et al. 1997. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278: 283-286.
10. Ulrichs, T., D. B. Moody, E. Grant, S. H. Kaufmann, and S. A. Porcelli. 2003. Tcell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect. Immun. 71: 3076-3087.
11. Nguyen, T. K., A. P. Koets, W. J. Santema, W. Van Eden, V. P. Rutten, and I. Van Rhijn. 2009. The mycobacterial glycolipid glucose monomycolate induces a memory T cell response comparable to a model protein antigen and no B cell response upon experimental vaccination of cattle. Vaccine 27: 4818-4825.
12. Hiromatsu, K., C. C. Dascher, K. P. LeClair, M. Sugita, S. T. Furlong, M. B. Brenner, and S. A. Porcelli. 2002. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J. Immunol. 169: 330-339.
13. Moody, D. B., M. R. Guy, E. Grant, T. Y. Cheng, M. B. Brenner, G. S. Besra, and S. A. Porcelli. 2000. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J. Exp. Med. 192: 965-976.
14. Moody, D. B., D. M. Zajonc, and I. A. Wilson. 2005. Anatomy of CD1-lipid antigen complexes. Nat. Rev. Immunol. 5: 387-399.
15. Van Rhijn, I., T. K. Nguyen, A. Michel, D. Cooper, M. Govaerts, T. Y. Cheng, W. Van Eden, D. B. Moody, J. A. Coetzer, V. Rutten, and A. P. Koets. 2009. Low cross-reactivity of T-cell responses against lipids from Mycobacterium bovis and M. avium paratuberculosis during natural infection. Eur. J. Immunol. 39: 3031-3041.
16. Kronenberg, M., and D. M. Zajonc. 2013. A "GEM" of a cell. Nat. Immunol. 14: 694-695.
17. Van Rhijn, I., N. A. Gherardin, A. Kasmar, W. De Jager, D. G. Pellicci, L. Kostenko, L. L. Tan, M. Bhati, S. Gras, D. I. Godfrey, et al. 2014. TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T Cell repertoire. J. Immunol. 192: 4054-4060.
18. Kaufmann, S. H. E. 2013. Tuberculosis vaccines: Time to think about the next generation. Semin. Immunol. 25: 172-181.
19. Ochoa, M. T., A. Loncaric, S. R. Krutzik, T. C. Becker, and R. L. Modlin. 2008. "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J. Invest. Dermatol. 128: 2225-2231.
20. Krutzik, S. R., B. Tan, H. Li, M. T. Ochoa, P. T. Liu, S. E. Sharfstein, T. G. Graeber, P. A. Sieling, Y. J. Liu, T. H. Rea, et al. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11: 653-660.
21. Moody, D. B. 2006. TLR gateways to CD1 function. Nat. Immunol. 7: 811-817.
22. Morse, M. A., R. Chapman, J. Powderly, K. Blackwell, T. Keler, J. Green, R. Riggs, L. Z. He, V. Ramakrishna, L. Vitale, et al. 2011. Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients. Clin. Cancer Res. 17: 4844-4853.
23. Trumpfheller, C., M. P. Longhi, M. Caskey, J. Idoyaga, L. Bozzacco, T. Keler, S. J. Schlesinger, and R. M. Steinman. 2012. Dendritic cell-targeted protein vaccines: A novel approach to induce T-cell immunity. J. Intern. Med. 271: 183-192.
24. Chen, W. C., G. C. Completo, D. S. Sigal, P. R. Crocker, A. Saven, and J. C. Paulson. 2010. In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood 115: 4778-4786.
25. Nycholat, C. M., C. Rademacher, N. Kawasaki, and J. C. Paulson. 2012. In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages. J. Am. Chem. Soc. 134: 15696-15699.
26. Kawasaki, N., J. L. Vela, C. M. Nycholat, C. Rademacher, A. Khurana, N. Van Rooijen, P. R. Crocker, M. Kronenberg, and J. C. Paulson. 2013. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation. Proc. Natl. Acad. Sci. USA 110: 7826-7831.
27. Chen, W. C., N. Kawasaki, C. M. Nycholat, S. Han, J. Pilotte, P. R. Crocker, and J. C. Paulson. 2012. Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS ONE 7: E39039.
28. Kiwamoto, T., N. Kawasaki, J. C. Paulson, and B. S. Bochner. 2012. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol. Ther. 135: 327-336.
29. O'Reilly, M. K., and J. C. Paulson. 2009. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol. Sci. 30: 240-248.
30. Crocker, P. R., J. C. Paulson, and A. Varki. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7: 255-266.
31. Miyazaki, K., K. Sakuma, Y. I. Kawamura, M. Izawa, K. Ohmori, M. Mitsuki, T. Yamaji, Y. Hashimoto, A. Suzuki, Y. Saito, et al. 2012. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and-9. J. Immunol. 188: 4690-4700.
32. Lock, K., J. Zhang, J. Lu, S. H. Lee, and P. R. Crocker. 2004. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology 209: 199-207.
33. Scott, C. J.,W. M. Marouf, D. J. Quinn, R. J. Buick, S. J. Orr, R. F. Donnelly, and P. A. McCarron. 2008. Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-coglycolide) nanoparticles. Pharm. Res. 25: 135-146.
34. Rillahan, C. D., E. Schwartz, C. Rademacher, R. McBride, J. Rangarajan, V. V. Fokin, and J. C. Paulson. 2013. On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7. ACS Chem. Biol. 8: 1417-1422.
35. Moody, D. B., V. Briken, T. Y. Cheng, C. Roura-Mir, M. R. Guy, D. H. Geho, M. L. Tykocinski, G. S. Besra, and S. A. Porcelli. 2002. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat. Immunol. 3: 435-442.
36. Li, Q., A. Lau, T. J. Morris, L. Guo, C. B. Fordyce, and E. F. Stanley. 2004. A syntaxin 1, Gao, and N-type calcium channel complex at a presynaptic nerve terminal: Analysis by quantitative immunocolocalization. J. Neurosci. 24: 4070-4081.
37. Cheng, T. Y., M. Relloso, I. Van Rhijn, D. C. Young, G. S. Besra, V. Briken, D. M. Zajonc, I. A. Wilson, S. Porcelli, and D. B. Moody. 2006. Role of lipid trimming and CD1 groove size in cellular antigen presentation. EMBO J. 25: 2989-2999.
38. Dascher, C. C., K. Hiromatsu, X. Xiong, C. Morehouse, G. Watts, G. Liu, D. N. McMurray, K. P. LeClair, S. A. Porcelli, and M. B. Brenner. 2003. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int. Immunol. 15: 915-925.
39. Lundberg, K., A.-S. Albrekt, I. Nelissen, S. Santegoets, T. D. De Gruijl, S. Gibbs, and M. Lindstedt. 2013. Transcriptional profiling of human dendritic cell populations and models: Unique profiles of in vitro dendritic cells and implications on functionality and applicability. PLoS ONE 8: E52875.
40. Bax, M., M. L. Kuijf, A. P. Heikema, W. Van Rijs, S. C. Bruijns, J. J. García-Vallejo, P. R. Crocker, B. C. Jacobs, S. J. Van Vliet, and Y. Van Kooyk. 2011. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect. Immun. 79: 2681-2689.
41. Varchetta, S., E. Brunetta, A. Roberto, J. Mikulak, K. L. Hudspeth, M. U. Mondelli, and D. Mavilio. 2012. Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes. PLoS ONE 7: e45821.